|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||0.00 / 0.00|
Hospira was a leading decliner within the health care sector, falling $0.39 (-1.1%) to $34.23 on light volume
The most recent short interest data has been released by the NASDAQ for the 04/30/2013 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.
In trading on Thursday, shares of Hospira Inc crossed above their 200 day moving average of $32.51, changing hands as high as $33.90 per share. Hospira Inc shares are currently trading up about 4.1% on the day.
Hospira was a leading decliner within the health care sector, falling 32 cents (-1%) to $30.59 on average volume.
Hospira was a leading decliner within the drugs industry, falling 59 cents (-2%) to $29.18 on average volume.
Hospira (NYSE:HSP) is trading at unusually high volume Tuesday with 3.9 million shares changing hands. It is currently at 2.1 times its average daily volume and trading up 87 cents (+3%).
Hospira (NYSE:HSP) is trading at unusually high volume Wednesday with 3.1 million shares changing hands. It is currently at 2.4 times its average daily volume and trading down 78 cents (-2.2%).
Thanks to European and Chinese inaction, American companies have been able to adjust and profit.
Hospira Management Discusses Q2 2012 Results - Earnings Call Transcript
Hospira's CEO Discusses Q1 2012 Results - Earnings Call Transcript
Hospira Management Discusses Q4 2011 Results - Earnings Call Transcript
UBS Investment Research recently highly these stocks in its review of the pharamaceutical sector.
Harwood Feffer LLP ( www.hfesq.
Hospira (NYSE:HSP) hit a new 52-week low Tuesday as it is currently trading at $27.55, below its previous 52-week low of $28.04 with five million shares traded as of 3:40 p.m. ET. Average volume has been 2.2 million shares over the past 30 days.
Faruqi & Faruqi, LLP, a leading national securities firm, is investigating potential securities fraud at Hospira, Inc.
Robbins Geller Rudman & Dowd LLP (“Robbins Geller”) ( http://www.
Holzer Holzer & Fistel, LLC is investigating potential violations of the federal securities laws by Hospira, Inc.
Hospira's CEO Discusses Q3 2011 Results - Earnings Call Transcript
Hospira (NYSE:HSP) hit a new 52-week low Wednesday as it is currently trading at $29.06, below its previous 52-week low of $34.18 with 1.1 million shares traded as of 10 a.m. ET. Average volume has been 1.5 million shares over the past 30 days.
Hospira shares were falling almost 20% after the drugmaker cut its 2011 earnings forecast.
Shares of Hospira (NYSE:HSP) were gapping down Tuesday morning with an open price 18.3% lower than Monday's closing price. The stock closed at $37.36 yesterday and opened today's trading at $30.52.
Hospira Inc was a leading decliner within the health care sector, falling 74 cents (-1.9%) to $38.02 on light volume.
Hospira (NYSE:HSP) has been downgraded by TheStreet Ratings from from a buy to hold.
Hewlett-Packard downgraded at BMO from Outperform to Market Perform. Texas Instruments downgraded at ThinkEquity from Buy to Hold.
Hospira's CEO Discusses Q2 2011 Results - Earnings Call Transcript
Hospira's CEO Discusses Q1 2011 Results - Earnings Call Transcript
Hospira Inc (NYSE:HSP) has been upgraded by TheStreet Ratings from a hold to buy.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.